Table 1

Demographic and endpoint data of the two groups
Group1 Group2 P value
Control group (76) treated group (389)
CKD stage number(percent) 0.99
3a:60>GFR≥45 14(18.4) 140(36.0)
3b:45>GFR≥30 number(percent) 35(46.1) 180(46.3)
4:30>GFR≥15 number(percent) 27(35.5) 69(17.7)
(GFRcc/min/1.73m2)
CKD stage (RRT+death)/total(%) 0.048*
3a: (3+0)/14(21.4) 34.66±11.03
3b: (9+2)/35(31.4) (11+5)/180(8.9)
4: (5+1)/27(22.2) (5+1)/69(8.7)
GFRcc/min/1.73m2 mean±SD 35.09±10.56 (38+7)/140(32.1) 0.753
Age(years) mean±SD 56.5±17.3 62.3±14.2 0.008*
Diabetes mellitus 23(30.3%) 130(33.4%) 0.328
Sex(Male/Female) 43/33=1.3 234/155=1.5 0.324
Anemia(Hb<11gr/dl) 13/48 42/203 0.218
Systolic HTN(>14CmHg) 32/60 113/312 0.010*
Systolic Blood pressure (CmHg) mean±SD 14.91±2.85 13.82±2.68 0.005*
Diastolic Blood pressure (CmHg) mean±SD 8.34±1.47 7.74±1.30 0.001*
Hemoglobin(gr/dl) mean±SD 12.58±2.51 12.61±2.03 0.913
Calcium(mg/dl) mean±SD 9.12±0.70 9.22±1.00 0.681
Phosphorus(mg/dl) mean±SD 4.30±1.07 4.04±0.77 0.348
Uric acid(mg/dl) mean±SD 7.45±1.84 9.46±12.84 0.549
Cholesterol(mg/dl) mean±SD 209.56±57.66 196.19±69.14 0.251
Triglyceride(mg/dl) mean±SD 266.14±181.11 192.40±119.00 0.048

Mahdavi-Mazdeh et al.

Mahdavi-Mazdeh et al. BMC Nephrology 2012 13:138   doi:10.1186/1471-2369-13-138

Open Data